Prescription of lipophilic statins to Alzheimer's disease patients: Some controversies to consider

Neurological Sciences

Volumn 32, Issue 2, 2011, Pages 195-201

  Biondi, Elisa ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Alzheimer's disease; Blood brain barrier (BBB); Cholesterol; Statins

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; ATORVASTATIN; CERIVASTATIN; CHOLESTEROL; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVALONIC ACID; MEVINOLIN; PRAVASTATIN; PROBUCOL; SIMVASTATIN; TRIACYLGLYCEROL;

ALZHEIMER DISEASE; ASTHMA; AUTOIMMUNE DISEASE; BRAIN NERVE CELL; CATALYSIS; CHOLESTEROL SYNTHESIS; COGNITIVE DEFECT; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG USE; HEART ARRHYTHMIA; HOMEOSTASIS; HUMAN; KIDNEY DISEASE; NONHUMAN; PRESCRIPTION; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SEPSIS; STROKE; TRANSIENT ISCHEMIC ATTACK;

ALZHEIMER DISEASE; BRAIN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPID METABOLISM;

EID: 79952860352     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-010-0440-0     Document Type: Review

References (58)

1. K Almuti R Rimawi D Spevack R Ostfeld 2006 Effects of statins beyond lipid lowering: potential for clinical benefits Int J Cardiol 109 7 15 16054715 10.1016/j.ijcard.2005.05.056
2. N Arispe M Doh 2002 Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1-40) and (1-42) peptides Faseb J 16 1526 1535 12374775 10.1096/fj.02-0829com 1:CAS:528:DC%2BD38XnvFWntrs%3D (Pubitemid 35154635)
3. Z Arvanitakis JA Schneider RS Wilson JL Bienras JF Kelly DA Evans DA Bennet 2008 Statins, incident Alzheimer disease, change in cognitive function, and neuropathology Neurology 70 1795 1802 18199831 10.1212/01.wnl.0000288181. 00826.63 1:CAS:528:DC%2BD1cXhtFahu7vO (Pubitemid 351653958)
4. 2 techniques in vivo and in vitro J Biol Chem 272 48 30178 30184 9374499 10.1074/jbc.272.48.30178 (Pubitemid 27512218)
5. C Cecchi A Pensalfini G Liguri S Baglioni C Fiorillo S Guadagna M Zampagni L Formigli D Nosi M Stefani 2008 Differentiation increases the resi stance of neuronal cells to amyloid toxicity Neurochem Res 33 2516 2531 18307032 10.1007/s11064-008-9627-7 1:CAS:528:DC%2BD1cXhtlOktL%2FK
6. D Champagne D Pearson D Dea J Rochford J Poirier 2003 The cholesterol-lowering drug Probucol increases apolipoprotein E production in the hippocampus of aged rats: implications for Alzheimer's disease Neuroscience 121 99 110 12946703 10.1016/S0306-4522(03)00361-0 1:CAS:528:DC%2BD3sXmslehtrY%3D (Pubitemid 37297617)
7. A Crameri E Biondi K Kuehnle D Lütjohann KM Thelen S Perga CG Dotti RM Nitsch MD Ledesma MH Mohajeri 2006 The role of seladin-1/DHCR24 in cholesterol biosynthesis and Aβ generation in vivo EMBO 25 2 432 443 10.1038/sj.emboj.7600938 1:CAS:528:DC%2BD28XntFSmtQ%3D%3D (Pubitemid 43152863)
8. JW Choi SE Jung 1999 Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells JPET 289 1 572 579 1:CAS:528:DyaK1MXit1Knt74%3D (Pubitemid 29156077)
9. PH Chong JD Seeger C Franklin 2001 Clinically relevant differences between the statins: implications for therapeutic selection Am J Med 111 390 400 11583643 10.1016/S0002-9343(01)00870-1 1:CAS:528:DC%2BD3MXnt1Shtbw%3D (Pubitemid 32913673)
10. M Culot S Lundquist D Vanuxeem S Nion C Landry Y Delplace MP Dehouck V Berezowski L Fenart R Cecchelli 2008 An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening Toxicol In Vitro 22 3 799 811 18280105 10.1016/j.tiv.2007.12.016 1:CAS:528:DC%2BD1cXjtVemtLo%3D
11. ST DeKosky 2005 Statin therapy in the treatment of Alzheimer disease: what is the rationale? Am J Med 118 12A 48S 53S 10.1016/j.amjmed.2005.09.006 1:CAS:528:DC%2BD28XmvFGjuw%3D%3D (Pubitemid 41779427)
12. Y Ohyama S Meaney M Heverin L Ekstrom A Brafman M Shafir U Andersson M Olin G Eggertsen U Diczfalusy E Feinstein I Bjorkhem 2006 Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes J Biol Chem 281 3810 3820 16321981 10.1074/jbc.M505179200 1:CAS:528:DC%2BD28XhtlKksb4%3D (Pubitemid 43847805)
13. A Peri M Serio 2008 Neuroprotective effects of the Alzheimer's Disease related gene seladin-1 J Mol Endocrinol 41 251 261 18768664 10.1677/JME-08-0071 1:CAS:528:DC%2BD1cXhsFaktr3P
14. GP Eckert NJ Cairns A Maras WF Gattaz WE Müller 2000 Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease Dement Geriatr Cogn Disord 11 181 186 10867442 10.1159/000017234 1:CAS:528:DC%2BD3cXls1Ojur4%3D (Pubitemid 30416021)
15. GP Eckert C Kirsch WE Mueller 2001 Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE-deficient mice NeuroReport 12 883 887 11303752 10.1097/00001756-200104170-00003 1:CAS:528:DC%2BD3MXjtVWhurk%3D (Pubitemid 32281439)
16. B Erdemli S Kilicoglu-Serin E Erdemli 2005 A new approach to the treatment of osteoporosis Orthopedics 28 59 62 15682577
17. K Faβbender M Stroick MD Bertsch A Ragoschke S Kuehl S Walter J Walter K Brechtel F Muehlhauser K von Bergmann D Lütjohann 2002 Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide Neurology 59 1257 1258 (Pubitemid 35192402)
18. D Gaist LA Rodriguez C Huerta J Hallas SH Sindrup 2001 Lipid-lowering drugs and risk of myopathy: a population-based follow-up study Epidemiology 12 5 565 569 11505177 10.1097/00001648-200109000-00017 1:STN:280: DC%2BD3MvlvVyrtA%3D%3D (Pubitemid 32761999)
19. DH Mauch K Nagler C Schumacher C Goritz EC Muller A Otto 2001 CNS synaptogenesis promoted by glia-derived cholesterol Science 294 1354 1357 11701931 10.1126/science.294.5545.1354 1:CAS:528:DC%2BD3MXotlKmu7c%3D (Pubitemid 33063104)
20. N García-Román AM Alvarez MJ Toro A Montes MJ Lorenzo 2001 Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition Mol Cell Neuros 17 329 341 10.1006/mcne.2000.0904 (Pubitemid 32176489)
21. S Gupta 2004 Does aggressive statin therapy offer improved cholesterol-independent benefits compared to conventional statin treatment? Int J Cardiol 96 131 139 15262025 10.1016/j.ijcard.2003.10.013 (Pubitemid 38979890)
22. S Hoyer P Riederer 2007 Alzheimer disease - no target for statin treatment. A mini review Neurochem Res 32 695 706 17063393 10.1007/s11064-006- 9168-x 1:CAS:528:DC%2BD2sXjtlyms7w%3D (Pubitemid 46481299)
23. N Kandiah H Feldman 2009 Therapeutic potential of statins in Alzheimer's disease J Neurol Sci 283 230 234 19321181 10.1016/j.jns.2009.02.352 1:CAS:528:DC%2BD1MXoslSitro%3D
24. C Kirsch GP Eckert WE Mueller 2002 Cholesterol attenuates the membrane perturbing properties of beta-amyloid peptides Amyloid 9 149 159 12408677 10.3109/13506120209114816 1:CAS:528:DC%2BD38XovVGksrY%3D (Pubitemid 35205204)
25. WE Klunk K Panchalingam RJ McClure JA Stanley JW Pettergrew 1998 Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4 Neurobiol Aging 19 6 511 515 10192209 10.1016/S0197-4580(98)00105-5 1:CAS:528:DyaK1MXitFamtLY%3D (Pubitemid 29117117)
26. EN Liberopoulos VG Athyros DP Mikhailidis 2006 Statins for non-alcoholic fatty liver disease: a new indication? Aliment Pharmacol Ther 24 695 699 10.1111/j.1365-2036.2006.03021.x (Pubitemid 44127854)
27. Y Osono LA Woollett J Herz JM Dietschy 1995 Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and accross the tissues of the mouse J Clin Invest 95 3 1124 1132 7883961 10.1172/JCI117760 1:CAS:528:DyaK2MXktlKhtbs%3D
28. D Lütjohann M Stroick T Bertsch S Kühl B Lindenthal K Thelen U Andersson I Björkhem K von Bergmann K Fassbender 2004 High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs Steroids 69 431 438 15219793 10.1016/j.steroids.2004.03.012 (Pubitemid 38829339)
29. AG Mainous III SL Eschenbach BJ Well CJ Everett JM Gill 2005 Cholesterol, transferrin saturation, and the development of dementia and Alzheimer's disease: results from an 18-year population-based cohort Fam Med 37 36 42 15619154 (Pubitemid 40094090)
30. EG Lund JM Guileyardo DW Russell 1999 cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain Proc Natl Acad Sci USA 96 7238 7243 10377398 10.1073/pnas.96.13.7238 1:CAS:528: DyaK1MXltVOrtbg%3D (Pubitemid 29299645)
31. RP Mason WJ Shoemaker L Shajenko TE Chambers LG Herbette 1992 Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol Neurobiol Aging 13 3 413 419 1625771 10.1016/0197-4580(92)90116-F 1:STN:280:DyaK38zis12msg%3D%3D
32. MM Mielke PP Zandi M Sjogren D Gustafson S Ostling B Steen I Skoog 2005 High total cholesterol levels in late life associated with a reduced risk of dementia Neurology 64 1689 1695 15911792 10.1212/01.WNL.0000161870.78572.A5 1:CAS:528:DC%2BD2MXktVKrurY%3D (Pubitemid 40695799)
33. G Mundy R Garret S Harris J Chan D Chen G Rossini 1999 Stimulation of bone formation in vitro and in rodents by statins Science 286 1946 1949 10583956 10.1126/science.286.5446.1946 1:CAS:528:DyaK1MXnvFSiu78%3D (Pubitemid 129515901)
34. Martin M, Dotti CG, Ledesma MD (2010) Brain cholesterol in normal and pathological aging. Biochim Biophys Acta (article in press)
35. K Paraskevas AA Tzovaras DD Briana DP Mikhailidis 2007 Emerging indications for statins: a pluripotent family of agents with several potential applications Curr Pharm Des 13 3622 3636 18220799 10.2174/138161207782794194 1:CAS:528:DC%2BD1cXnsVOgsw%3D%3D (Pubitemid 350238933)
36. I Parka EM Hwanga HS Honga JH Booa SS Oha J Leed MW Jungb OY Bangc SU Kima I Mook-Jung 2003 Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice Neurobiol Aging 24 5 637 643 10.1016/S0197-4580(02)00155-0 (Pubitemid 37288863)
37. Pensalfini A, Zampagni M, Liguri G, Becatti M, Evangelisti E, Fiorillo C, Bagnoli S, Cellini E, Nacmias B, Sorbi S, Cecchi C (2009) Membrane cholesterol enrichment prevents Aβ-induced oxidative stress in Alzheimer's fibroblasto. Neurobiol Aging (article in press)
38. SE Wahrle H Jiang M Parsadanian J Legleiter X Han JD Fryer T Kowalewski DM Holtzman 2004 ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted ApoE J Biol Chem 279 40987 40993 15269217 10.1074/jbc.M407963200 1:CAS:528:DC%2BD2cXnslWnu78%3D (Pubitemid 39287699)
39. RG Riekse G Li EC Petrie JB Leverenz D Vavrek S Vuletic JJ Albers TJ Montine VM Lee M Lee P Seubert D Galasko GD Schellenberg WR Hazzard ER Peskind 2006 Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid JAD 10 399 406 17183151 1:CAS:528:DC%2BD28Xhtlansr7N
40. MO Romanitan BO Popescu B Winblad OA Bajenaru N Bogdanovic 2007 Occludin is overexpressed in Alzheimer's disease and vascular dementia J Cell Mol Med 11 3 569 579 17635647 10.1111/j.1582-4934.2007.00047.x 1:CAS:528: DC%2BD2sXpvVKjtro%3D (Pubitemid 47153465)
41. A Saheki T Terasaki I Tamai A Tsuji 1994 In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors Pharm Res 11 2 305 311 8165193 10.1023/A:1018975928974 1:CAS:528:DyaK2cXitVOrtLs%3D (Pubitemid 24076229)
42. BJ Satyawan J Girish Kumar 2006 Statins and osteoporosis: new role for old drugs JPP 58 3 18
43. I Bjorkhem 2009 Are side-chain oxidized oxysterols regulators also in vivo? J Lipid Res 50 Suppl S213 S218 18952574 10.1194/jlr.R800025-JLR200
44. MA Shibata Y Ito J Morimoto Y Otsuki 2004 Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism Carcinogenesis 25 1887 1898 15180944 10.1093/carcin/bgh201 1:CAS:528:DC%2BD2cXnvVOqt74%3D (Pubitemid 39405908)
45. I Shirakawa M Sata A Saiura Y Kaneda H Yasshiro Y Hirata 2007 Atorvastatin attenuates transplant-associated coronary arteriosclerosis in a murine model of cardiac transplantation Biomed Pharmacother 61 154 159 17258886 10.1016/j.biopha.2006.09.017 1:CAS:528:DC%2BD2sXkt1akur0%3D (Pubitemid 46562557)
46. M Simons F Schwarzler D Lütjohann K von Bergmann K Beyreuther J Dichgans H Wormstall T Hartmann JB Schulz 2002 Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: a 26-week randomized, placebo-controlled, double-blind trial Ann Neurol 52 346 350 12205648 10.1002/ana.10292 1:CAS:528:DC%2BD38Xns1amtr4%3D (Pubitemid 35001502)
47. L Starck A Lövgren-Sandblom I Björkhem 2002 Simvastatin treatment in the SLO syndrome: a safe approach? Am J Med Genet 113 183 189 12407710 10.1002/ajmg.10722 (Pubitemid 35231551)
48. P Strazzullo SM Kerry A Barbato M Versiero L D'Elia FP Cappuccio 2007 Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials Hypertension 49 792 798 17309949 10.1161/01.HYP.0000259737.43916.42 1:CAS:528:DC%2BD2sXivVamt7w%3D (Pubitemid 351664226)
49. DR Riddell H Zhou K Atchison HK Warwick PJ Atkinson J Jefferson L Xu S Aschmies Y Kirksey Y Hu E Wagner A Parratt J Xu Z Li MM Zaleska JS Jacobsen MM Pangalos PH Reinhart 2008 Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels J Neurosci 28 11445 11453 18987181 10.1523/JNEUROSCI.1972-08. 2008 1:CAS:528:DC%2BD1cXhtlOgtrfK
50. N Bogdanovic L Bretillon EG Lund 2001 On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells Neurosci Lett 314 45 48 11698143 10.1016/S0304-3940(01)02277-7 1:CAS:528:DC%2BD3MXotFSrsr8%3D (Pubitemid 33043802)
51. R Deane Z Wu A Sagare J Davis 2004 LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms Neuron 43 333 344 15294142 10.1016/j.neuron.2004.07.017 1:CAS:528:DC%2BD2cXmvFOisLY%3D (Pubitemid 39061126)
52. C Vauthey GR de Freitas G van Melle 2000 Better outcome after stroke with higher serum cholesterol levels Neurology 54 1944 1949 10822434 1:STN:280:DC%2BD3c3osVWgsQ%3D%3D
53. S Vuletic ER Peskind SM Marcovina JF Quinn MC Cheung H Kennedy JA Kaye L Jin JJ Albers 2005 Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro J Neuros Res 80 406 413 10.1002/jnr.20458 1:CAS:528:DC%2BD2MXjvFakt74%3D (Pubitemid 40780829)
54. ML Voytko R Murray CJ Higgs 2009 Executive function and attention are preserved in older surgically menopausal monkeys receiving estrogen or estrogen plus progesterone J Neurosci 29 10362 10370 19692611 10.1523/JNEUROSCI.1591-09. 2009 1:CAS:528:DC%2BD1MXhtVKqt7fP
55. M Wollmer JR Streffer D Lutjohann M Tsolaki 2003 ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease Neurobiol Aging 24 421 426 12600718 10.1016/S0197-4580(02)00094-5 1:CAS:528:DC%2BD3sXhsVantbk%3D (Pubitemid 36205049)
56. V Hirsch-Reinshagen S Zhou BL Burgess L Bernier SA McIsaac JY Chan GH Tansley JS Cohn MR Hayden CL Wellington 2004 Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain J Biol Chem 279 41197 41207 15269218 10.1074/jbc.M407962200 1:CAS:528:DC%2BD2cXnslWms7o%3D (Pubitemid 39287722)
57. BA Yankner LK Duffy DA Kirschner 1990 Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides Science 250 279 282 2218531 10.1126/science.2218531 1:CAS:528:DyaK3MXlslansg%3D%3D
58. H Zeng K Horie L Madisen MN Pavlova G Gragerova AD Rohde BA Schimpf Y Liang E Ojala F Kramer P Roth O Slobodskaya I Dolka EA Southon L Tessarollo K Bornfeldt A Gragerov GN Pavlakis GA Gaitanaris 2008 An inducible and reversible mouse genetic rescue system PLoS Genetics 4 5 1 13 10.1371/journal.pgen.1000069 (Pubitemid 351811505)